AstraZeneca said to have explored Bristol Myers merger

AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.

The companies have held early-stage discussions about combining, the people added, asking not to be identified because the matter is private.

It’s unclear if discussions are ongoing or whether they will result in a........

© Fortune